Harnessing Predictive Enrichment Strategies for ARDS Clinical Trials; Past, Present & Future
Time: 1:25 pm
day: Day One
- Understanding and leveraging heterogeneity within the syndrome of ARDS to prospectively identify treatment-responsive subtypes: what have we learned?
- Divulging the challenges of rapid identification of ARDS subphenotypes of interest
- Navigating matching biomarker credentials to trial design